Sleep Apnea Implants Market – By Product (Hypoglossal Neurostimulation Devices, Palatal Implants, Bone Screw Systems, Phrenic Nerve Stimulators), By Indication (Central Sleep Apnea, Obstructive Sleep Apnea), By End Use (Hospitals, ASCs) & Forecast, 2024 – 2032

North America sleep apnea implants industry was valued at USD 358.3 million in 2023 and is predicted to record a CAGR of 14.3% through 2032, attributed to the high prevalence of sleep apnea, well-established healthcare infrastructure, and growing public awareness.

Sleep apnea implants industry was valued at USD 461.2 million in 2023 and is anticipated to witness a CAGR of 14.8% through 2032, driven by the increasing prevalence of obstructive sleep apnea, low compliance & adherence towards CPAP, and rising awareness regarding sleep apnea.

Asahi Kasei Corporation, Inspire Medical System, Medtronic plc, Nyxoah SA, and Siesta Medical, Inc. among others.

The obstructive sleep apnea segment was valued at USD 432 million in 2023 and will grow as it provides a more comfortable and effective long-term solution, and preference among healthcare providers.